This analysis demonstrates that nitric oxide reduces PI4P levels in β-cells, showing selective prevention of EMCV replication.
Viral infection, particularly by members of the picornavirus family, has been associated with autoimmune diabetes (T1D) onset. The encephalomyocarditis virus (EMCV) is a mouse-tropic member of the picornavirus family that stimulates innate immune activation, leading to the production of cytokines. In response to cytokines, β-cells express inducible nitric oxide synthase (iNOS) and produce low micromolar levels of the free radical, nitric oxide. We have previously shown that, due to its inhibitory action on mitochondrial oxidation and depletion of cellular ATP, nitric oxide selectively attenuates EMCV replication in and lysis of β-cells. In this study, we show that one mechanism by which nitric oxide inhibits EMCV replication is by attenuating the accumulation of phosphatidylinositol-4-phosphate (PI4P) at the endoplasmic reticulum (ER) membrane. As a result, viral replication complex formation is prohibited, and viral replication is effectively prevented. In agreement with previous studies, we show that these observations are selective for β-cells and due to a loss of cellular ATP.
No takes yet. Share an insight, caveat, or question.
Gehant et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: